血管生成标志物在胎儿生长受限妊娠中的预后价值
该回顾性研究纳入2013至2020年维也纳医科大学93例单胎胎儿生长受限且疑似子痫前期的孕妇,采样检测sFlt-1与PlGF。sFlt-1/PlGF比值对采样后1周内子痫前期的AUC为0.87,优于单独sFlt-1的0.82和PlGF的0.72。以<38为界值排除2周内子痫前期的阴性预测值为0.933、敏感度为0.952。
要点
- sFlt-1/PlGF比值预测1周内子痫前期AUC 0.87,优于单独sFlt-1(0.82)和PlGF(0.72)。
- 以<38为界值排除2周内子痫前期,阴性预测值0.933、敏感度0.952。
- sFlt-1/PlGF比值的风险分层能力在2周时间点之后下降。
核心结论
- 在胎儿生长受限妊娠中,sFlt-1/PlGF比值预测子痫前期优于单独使用PlGF;已建立的短期排除界值在这些患者中似乎有效。
研究设计与样本
- 回顾性研究,纳入2013至2020年维也纳医科大学93例单胎胎儿生长受限妊娠(按Delphi共识标准定义)且因疑似子痫前期采样检测sFlt-1和PlGF的孕妇;采样时已确诊子痫前期者排除;采用Cox回归和logistic回归分析。
诊断标准与关键数值
- sFlt-1/PlGF比值预测采样后1周内子痫前期AUC 0.87,单独sFlt-1 AUC 0.82,单独PlGF AUC 0.72;含sFlt-1/PlGF比值模型的concordance index 0.790,含sFlt-1模型0.759,含PlGF模型0.755;sFlt-1/PlGF比值<38排除2周内子痫前期,阴性预测值0.933、敏感度0.952。
临床应用与阅片要点
- 在胎儿生长受限且疑似子痫前期的孕妇中,可依据sFlt-1/PlGF比值(界值<38)短期排除子痫前期;sFlt-1/PlGF比值的风险分层能力在2周时间点之后下降。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Pregnancies with fetal growth restriction (FGR) are at increased risk for pre-eclampsia. Angiogenic markers including soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) are altered in pregnancies complicated by FGR, but their utility for predicting pre-eclampsia in growth-restricted pregnancies is uncertain. This study aimed to evaluate the prognostic value of angiogenic markers for predicting the development of pre-eclampsia in pregnancies with FGR and suspected pre-eclampsia.
METHODS: This was a retrospective study of singleton pregnancies with FGR, defined according to Delphi consensus criteria, which underwent sampling of sFlt-1 and PlGF for suspicion of pre-eclampsia at the Medical University of Vienna, Vienna, Austria, between 2013 and 2020. Women with an established diagnosis of pre-eclampsia at sampling were excluded. Cox regression analysis and logistic regression analysis were performed to evaluate the association of angiogenic markers with the development of pre-eclampsia at various timepoints.
RESULTS: In this cohort of 93 women, pre-eclampsia was diagnosed in 14 (15.1%) women within 1 week after sampling, 21 (22.6%) within 2 weeks after sampling and 38 (40.9%) at any time after assessment. The sFlt-1/PlGF ratio consistently showed a stronger association with the development of pre-eclampsia compared to sFlt-1 or PlGF alone (pre-eclampsia within 1 week: area under the receiver-operating-characteristics curve, 0.87 vs 0.82 vs 0.72). Models including the sFlt-1/PlGF ratio were associated more strongly with pre-eclampsia hazard compared to models including sFlt-1 or PlGF alone (concordance index, 0.790 vs 0.759 vs 0.755). The risk classification capability of the sFlt-1/PlGF ratio decreased after the 2-week timepoint. The established cut-off value for the sFlt-1/PlGF ratio of < 38 was effective for ruling out pre-eclampsia within 2 weeks, with a negative predictive value of 0.933 and sensitivity of 0.952.
CONCLUSIONS: Use of the sFlt-1/PlGF ratio is preferrable to the use of PlGF alone for the prediction of pre-eclampsia in pregnancies with FGR. Established cut-offs for ruling out the development of pre-eclampsia in the short term seem to be effective in these patients. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Palmrich P, Kalafat E, Pateisky P, et al. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction. Ultrasound Obstet Gynecol. 2024. PMID: 37774098. doi:10.1002/uog.27509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。